Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells.

Galmarini CM, Martin M, Bouchet BP, Guillen-Navarro MJ, Martínez-Diez M, Martinez-Leal JF, Akhmanova A, Aviles P.

BMC Cancer. 2018 Feb 7;18(1):164. doi: 10.1186/s12885-018-4086-2.

2.

Microtubules in 3D cell motility.

Bouchet BP, Akhmanova A.

J Cell Sci. 2017 Jan 1;130(1):39-50. doi: 10.1242/jcs.189431. Review.

3.

Mesenchymal Cell Invasion Requires Cooperative Regulation of Persistent Microtubule Growth by SLAIN2 and CLASP1.

Bouchet BP, Noordstra I, van Amersfoort M, Katrukha EA, Ammon YC, Ter Hoeve ND, Hodgson L, Dogterom M, Derksen PWB, Akhmanova A.

Dev Cell. 2016 Dec 19;39(6):708-723. doi: 10.1016/j.devcel.2016.11.009. Epub 2016 Dec 8.

4.

Molecular Pathway of Microtubule Organization at the Golgi Apparatus.

Wu J, de Heus C, Liu Q, Bouchet BP, Noordstra I, Jiang K, Hua S, Martin M, Yang C, Grigoriev I, Katrukha EA, Altelaar AFM, Hoogenraad CC, Qi RZ, Klumperman J, Akhmanova A.

Dev Cell. 2016 Oct 10;39(1):44-60. doi: 10.1016/j.devcel.2016.08.009. Epub 2016 Sep 22.

5.

Talin-KANK1 interaction controls the recruitment of cortical microtubule stabilizing complexes to focal adhesions.

Bouchet BP, Gough RE, Ammon YC, van de Willige D, Post H, Jacquemet G, Altelaar AM, Heck AJ, Goult BT, Akhmanova A.

Elife. 2016 Jul 13;5. pii: e18124. doi: 10.7554/eLife.18124.

6.

Negative regulation of EB1 turnover at microtubule plus ends by interaction with microtubule-associated protein ATIP3.

Velot L, Molina A, Rodrigues-Ferreira S, Nehlig A, Bouchet BP, Morel M, Leconte L, Serre L, Arnal I, Braguer D, Savina A, Honore S, Nahmias C.

Oncotarget. 2015 Dec 22;6(41):43557-70. doi: 10.18632/oncotarget.6196.

7.

SCARECROW-LIKE23 and SCARECROW jointly specify endodermal cell fate but distinctly control SHORT-ROOT movement.

Long Y, Goedhart J, Schneijderberg M, Terpstra I, Shimotohno A, Bouchet BP, Akhmanova A, Gadella TW Jr, Heidstra R, Scheres B, Blilou I.

Plant J. 2015 Nov;84(4):773-84. doi: 10.1111/tpj.13038.

8.

Arabidopsis BIRD Zinc Finger Proteins Jointly Stabilize Tissue Boundaries by Confining the Cell Fate Regulator SHORT-ROOT and Contributing to Fate Specification.

Long Y, Smet W, Cruz-Ramírez A, Castelijns B, de Jonge W, Mähönen AP, Bouchet BP, Perez GS, Akhmanova A, Scheres B, Blilou I.

Plant Cell. 2015 Apr;27(4):1185-99. doi: 10.1105/tpc.114.132407. Epub 2015 Mar 31.

9.

Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.

The I, Ruijtenberg S, Bouchet BP, Cristobal A, Prinsen MB, van Mourik T, Koreth J, Xu H, Heck AJ, Akhmanova A, Cuppen E, Boxem M, Muñoz J, van den Heuvel S.

Nat Commun. 2015 Jan 6;6:5906. doi: 10.1038/ncomms6906.

10.

PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors.

Martínez-Díez M, Guillén-Navarro MJ, Pera B, Bouchet BP, Martínez-Leal JF, Barasoain I, Cuevas C, Andreu JM, García-Fernández LF, Díaz JF, Avilés P, Galmarini CM.

Biochem Pharmacol. 2014 Apr 1;88(3):291-302. doi: 10.1016/j.bcp.2014.01.026. Epub 2014 Jan 31.

PMID:
24486569
11.

CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor.

van der Vaart B, van Riel WE, Doodhi H, Kevenaar JT, Katrukha EA, Gumy L, Bouchet BP, Grigoriev I, Spangler SA, Yu KL, Wulf PS, Wu J, Lansbergen G, van Battum EY, Pasterkamp RJ, Mimori-Kiyosue Y, Demmers J, Olieric N, Maly IV, Hoogenraad CC, Akhmanova A.

Dev Cell. 2013 Oct 28;27(2):145-160. doi: 10.1016/j.devcel.2013.09.010. Epub 2013 Oct 10.

12.

PLA2R1 kills cancer cells by inducing mitochondrial stress.

Augert A, Vindrieux D, Girard CA, Le Calvé B, Gras B, Ferrand M, Bouchet BP, Puisieux A, de Launoit Y, Simonnet H, Lambeau G, Bernard D.

Free Radic Biol Med. 2013 Dec;65:969-977. doi: 10.1016/j.freeradbiomed.2013.08.177. Epub 2013 Aug 29.

PMID:
23994771
13.

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics.

Molina A, Velot L, Ghouinem L, Abdelkarim M, Bouchet BP, Luissint AC, Bouhlel I, Morel M, Sapharikas E, Di Tommaso A, Honoré S, Braguer D, Gruel N, Vincent-Salomon A, Delattre O, Sigal-Zafrani B, André F, Terris B, Akhmanova A, Di Benedetto M, Nahmias C, Rodrigues-Ferreira S.

Cancer Res. 2013 May 1;73(9):2905-15. doi: 10.1158/0008-5472.CAN-12-3565. Epub 2013 Feb 8.

14.

Microtubule plus-end tracking proteins SLAIN1/2 and ch-TOG promote axonal development.

van der Vaart B, Franker MA, Kuijpers M, Hua S, Bouchet BP, Jiang K, Grigoriev I, Hoogenraad CC, Akhmanova A.

J Neurosci. 2012 Oct 17;32(42):14722-8. doi: 10.1523/JNEUROSCI.1240-12.2012.

15.

βIII-Tubulin is required for interphase microtubule dynamics in untransformed human mammary epithelial cells.

Bouchet BP, Puisieux A, Galmarini CM.

Eur J Cell Biol. 2011 Oct;90(10):872-8. doi: 10.1016/j.ejcb.2011.05.005. Epub 2011 Aug 4.

PMID:
21820201
16.

p21(Cip1) regulates cell-substrate adhesion and interphase microtubule dynamics in untransformed human mammary epithelial cells.

Bouchet BP, Fauvet F, Grelier G, Galmarini CM, Puisieux A.

Eur J Cell Biol. 2011 Aug;90(8):631-41. doi: 10.1016/j.ejcb.2011.03.002. Epub 2011 May 11.

PMID:
21561680
17.

Cabazitaxel, a new taxane with favorable properties.

Bouchet BP, Galmarini CM.

Drugs Today (Barc). 2010 Oct;46(10):735-42. doi: 10.1358/dot.2010.46.10.1519019. Review.

PMID:
21076710
18.

The SNAIL family member SCRATCH1 is not expressed in human tumors.

Bastid J, Bouchet BP, Ciancia C, Pourchet J, Audoynaud C, Grelier G, Puisieux A, Ansieau S.

Oncol Rep. 2010 Feb;23(2):523-9.

PMID:
20043117
19.

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.

Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A.

Cancer Cell. 2008 Jul 8;14(1):79-89. doi: 10.1016/j.ccr.2008.06.005.

20.

Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.

Bouchet BP, Bertholon J, Falette N, Audoynaud C, Lamblot C, Puisieux A, Galmarini CM.

Br J Cancer. 2007 Nov 5;97(9):1218-24. Epub 2007 Oct 30.

21.

Weekly administration of paclitaxel induces long-term aneugenicity in nude mice.

Galmarini CM, Bouchet BP, Falette N, Vila L, Lamblot C, Audoynaud C, Bertholon J, Puisieux A.

Cancer Biol Ther. 2007 Mar;6(3):377-82. Epub 2007 Mar 13.

PMID:
17264671
22.

p53 as a target for anti-cancer drug development.

Bouchet BP, Caron de Fromentel C, Puisieux A, Galmarini CM.

Crit Rev Oncol Hematol. 2006 Jun;58(3):190-207. Epub 2006 May 9. Review.

PMID:
16690321
23.

A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells.

Galmarini CM, Bouchet BP, Audoynaud C, Lamblot C, Falette N, Bertholon J, Wang Q, Beghin A, Dumontet C, Puisieux A.

Int J Cancer. 2006 Jul 1;119(1):60-6.

Supplemental Content

Loading ...
Support Center